OA06372A - Nouveaux aryltrifluoroéthanols, leur procédé d'obtention et leur emploi en thérapeutique. - Google Patents

Nouveaux aryltrifluoroéthanols, leur procédé d'obtention et leur emploi en thérapeutique.

Info

Publication number
OA06372A
OA06372A OA56933A OA56933A OA06372A OA 06372 A OA06372 A OA 06372A OA 56933 A OA56933 A OA 56933A OA 56933 A OA56933 A OA 56933A OA 06372 A OA06372 A OA 06372A
Authority
OA
OAPI
Prior art keywords
aryltrifluoroethanols
therapy
obtaining
new
new aryltrifluoroethanols
Prior art date
Application number
OA56933A
Other languages
English (en)
Inventor
Michel Vincent
Georges Remond
Jacques Bure
Original Assignee
Science Union & Cie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Science Union & Cie filed Critical Science Union & Cie
Publication of OA06372A publication Critical patent/OA06372A/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/096—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/26—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pain & Pain Management (AREA)
  • Public Health (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Hydrogenated Pyridines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyridine Compounds (AREA)
OA56933A 1978-11-03 1979-11-03 Nouveaux aryltrifluoroéthanols, leur procédé d'obtention et leur emploi en thérapeutique. OA06372A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7831096A FR2440353A1 (fr) 1978-11-03 1978-11-03 Nouveaux arylethanols, leurs procedes d'obtention et leur emploi comme medicament

Publications (1)

Publication Number Publication Date
OA06372A true OA06372A (fr) 1981-08-31

Family

ID=9214422

Family Applications (2)

Application Number Title Priority Date Filing Date
OA56933A OA06372A (fr) 1978-11-03 1979-11-03 Nouveaux aryltrifluoroéthanols, leur procédé d'obtention et leur emploi en thérapeutique.
OA56934A OA06373A (fr) 1978-11-03 1979-11-03 Nouvelles compositions pharmaceutiques à base d'aryltrifluoroétanols.

Family Applications After (1)

Application Number Title Priority Date Filing Date
OA56934A OA06373A (fr) 1978-11-03 1979-11-03 Nouvelles compositions pharmaceutiques à base d'aryltrifluoroétanols.

Country Status (27)

Country Link
US (2) US4285943A (fr)
JP (2) JPS5566510A (fr)
AR (2) AR223989A1 (fr)
AT (1) AT368483B (fr)
AU (1) AU527630B2 (fr)
BE (2) BE879786A (fr)
CA (2) CA1139763A (fr)
CH (2) CH647225A5 (fr)
DD (2) DD147048A5 (fr)
DE (2) DE2944294A1 (fr)
DK (2) DK461579A (fr)
EG (1) EG14114A (fr)
ES (1) ES485656A0 (fr)
FI (2) FI793445A7 (fr)
FR (1) FR2440353A1 (fr)
GB (2) GB2034587B (fr)
GR (2) GR68015B (fr)
IL (2) IL58620A (fr)
IT (2) IT7950715A0 (fr)
MA (2) MA18628A1 (fr)
NL (2) NL7908099A (fr)
NZ (2) NZ192021A (fr)
OA (2) OA06372A (fr)
PT (2) PT70407A (fr)
SE (2) SE7909105L (fr)
SU (1) SU925247A3 (fr)
ZA (2) ZA795871B (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5965606A (en) * 1995-12-29 1999-10-12 Allergan Sales, Inc. Methods of treatment with compounds having RAR.sub.α receptor specific or selective activity
US6673784B1 (en) 1996-03-19 2004-01-06 G. D. Searle & Co. Electrophilic ketones for the treatment of herpesvirus infections
ITRM20050389A1 (it) 2005-07-22 2007-01-23 Giuliani Spa Composti e loro sali specifici per i recettori ppar ed i recettori per l'egf e loro uso in campo medico.
UA107562C2 (uk) 2008-12-05 2015-01-26 Спосіб лікування псоріазу
HRP20170936T1 (hr) 2009-02-16 2017-09-22 Nogra Pharma Limited Alkilamido spojevi i njihova uporaba
WO2013117744A2 (fr) 2012-02-09 2013-08-15 Nogra Pharma Limited Méthodes de traitement de la fibrose
NZ631049A (en) 2012-04-18 2017-02-24 Nogra Pharma Ltd Methods of treating lactose intolerance
AU2020217884B2 (en) 2019-02-08 2025-02-20 Nogra Pharma Limited Process of making 3-(4'-aminophenyl)-2-methoxypropionic acid, and analogs and intermediates thereof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3142683A (en) * 1961-08-14 1964-07-28 Parke Davis & Co 1-pyridyl-1, 2-diaryl-3-trifluoro-propan-2-ols and a process for their preparation
US3531487A (en) * 1966-10-25 1970-09-29 Hoffmann La Roche 4-(n,n-disubstituted-amino)-piperidines
DE1618007A1 (de) * 1967-05-09 1970-10-29 Thomae Gmbh Dr K Verfahren zur Herstellung von neuen Amino-monohalogenphenylaethanolaminen
US3821231A (en) * 1971-10-15 1974-06-28 E Lavrinovich Method for preparation of n-substituted 4-aniline piperidines
GB1411783A (en) * 1972-02-24 1975-10-29 Wyeth John & Brother Ltd Piperidine derivatives
FR2340734A1 (fr) * 1976-02-13 1977-09-09 Roussel Uclaf Nouveaux derives de la m-trifluoromethylphenyl piperidine et leurs sels, procede de preparation et application a titre de medicaments
DE2659117A1 (de) * 1976-12-28 1978-07-06 Consortium Elektrochem Ind Trichlormethyl-(3-pyridyl)-carbinol
SU884568A3 (ru) * 1977-10-07 1981-11-23 Сьянс Юньон Э Ко.,Сосьете Франсэз Де Решерш Медикаль(Фирма) Способ получени (арилалкил) алкановых кислот

Also Published As

Publication number Publication date
NZ192020A (en) 1982-12-21
DD147048A5 (de) 1981-03-18
MA18628A1 (fr) 1980-07-01
BE879787A (fr) 1980-04-30
CA1139763A (fr) 1983-01-18
GR69726B (fr) 1982-07-09
SU925247A3 (ru) 1982-04-30
CH641043A5 (fr) 1984-02-15
IL58620A (en) 1982-12-31
AU5241679A (en) 1980-05-08
GR68015B (fr) 1981-10-27
SE7909106L (sv) 1980-05-04
SE7909105L (sv) 1980-05-04
PT70407A (en) 1979-12-01
PT70408A (fr) 1979-12-01
DK461679A (da) 1980-05-04
FR2440353A1 (fr) 1980-05-30
OA06373A (fr) 1981-08-31
GB2034587B (en) 1983-02-09
AT368483B (de) 1982-10-11
GB2034587A (en) 1980-06-11
GB2038802A (en) 1980-07-30
GB2038802B (en) 1982-12-08
IL58621A0 (en) 1980-02-29
ZA795871B (en) 1980-10-29
FI793444A7 (fi) 1981-01-01
CA1142087A (fr) 1983-03-01
AR223989A1 (es) 1981-10-15
US4404215A (en) 1983-09-13
ES8101538A1 (es) 1980-12-16
ES485656A0 (es) 1980-12-16
MA18629A1 (fr) 1980-07-01
NL7908101A (nl) 1980-05-07
BE879786A (fr) 1980-04-30
IT7950715A0 (it) 1979-10-31
DE2944293A1 (de) 1980-05-08
ZA795870B (en) 1980-10-29
NZ192021A (en) 1982-09-07
AR223990A1 (es) 1981-10-15
JPS5566510A (en) 1980-05-20
DD151445A5 (de) 1981-10-21
US4285943A (en) 1981-08-25
AU527630B2 (en) 1983-03-17
IL58620A0 (en) 1980-02-29
DE2944294A1 (de) 1980-05-08
NL7908099A (nl) 1980-05-07
FI793445A7 (fi) 1981-01-01
ATA701679A (de) 1982-02-15
EG14114A (en) 1983-03-31
IT7950714A0 (it) 1979-10-31
DK461579A (da) 1980-05-04
CH647225A5 (fr) 1985-01-15
JPS5566548A (en) 1980-05-20

Similar Documents

Publication Publication Date Title
LU80081A1 (fr) Nouvelles hydroxymethyl-5 oxazolidinones-2,leur procede de preparation et leur application therapeutique
FR2328508A1 (fr) Gels poreux, leur procede d'obtention et applications
FR2348911A1 (fr) Nouveaux nitroaminophenols substitues,leur procede d'obtention et compositions tinctoriales les contenant
OA05685A (fr) Procédé d'extraction en continu.
BE873447A (fr) Derives de 1,2,4-oxadiazole, leur procede de preparation et leur utilisation
LU76848A1 (fr) Nouveaux hydroxymethyl-5 oxazolidinone-2, leur procede de preparation et leur application therapeutique
BE866031A (fr) Nouveaux 2-(2,2-diarylalkyl)-1-azabicyclo (2,2,2)octanes, utiles notamment comme antidiarrheiques, et leur procede de preparation
FR2458547B2 (fr) Nouvelles n-aryle azolones, leur procede de preparation et leur application en therapeutique
BE844066A (fr) Nouveaux ethers de 2', 3,6'-trichloro-4-cyano-4'-benzoylureidodiphenyle, leur procede de preparation et leur application
BE880220A (fr) 1,2,4,5-tetra-alkyl-4-arylpiperidines, leur utilisation therapeutique, leur preparation et les intermediaires appropries
FR2506306B1 (fr) Nouveaux derives de l'amidinopiperidine, leur procede de preparation et leur application en therapeutique
OA06372A (fr) Nouveaux aryltrifluoroéthanols, leur procédé d'obtention et leur emploi en thérapeutique.
FR2299352A1 (fr) Polythiols contenant des groupes d'urethanne, et leur preparation
OA06415A (fr) Nouvelles trifluoroéthylamines substituées, leurs procédés d'obtention et leur emploi comme médicament.
BE844229A (fr) Nouveaux derives d'apovincaminol leur procede de preparation et leur application
FR2319350A1 (fr) Nouveaux 3-aminoalcoxyphenyl-2, 3, 3a, 4-tetrahydro-indeno-, 2h-naphto- et benzocyclohepta(l,2-c)pyrazoles, utiles notamment comme antidepresseurs et leur procede de preparation
OA06094A (fr) Procédé pour l'obtention d'alkylthiosulfates et d'alkylidènethiosulfates.
OA06127A (fr) Nouveaux éthers d'azolylakyle et de pyridinyle, leur procédé de production et leur application comme fongicides.
EP0270682A4 (fr) Nouveaux complexes, procede pour leur preparation, et leur emploi medicinal.
BE861500R (fr) Nouveaux derives d'isoxazoles, leur procde de preparation et leur applications
BE849013A (fr) Nouveaux diphenylacetamides, leur procede d'obtention et leur emploi comme medicament
BE880292A (fr) Nouveaux acides oxy-cyclohexylacetiques substitues, leur procede de preparation et leur application en therapeutique
FR2309221A1 (fr) N-acyl glutamines et leur procede d'obtention
BE848489A (fr) Halogenures d'acides sulfamiques et leur preparation,
BE851372A (fr) Nouvelles propylenediamides et leur procede d'obtention